GLENDALE, Calif.–(BUSINESS WIRE)–Public Storage (NYSE:PSA) (“Public Storage” or the “Company”) today provided certain updates as…
OptimHire provides a much-needed solution to the current talent shortage crisis by allowing organizations to…
Featuring faster page turns and color switching for eReader Market BILLERICA, Mass.–(BUSINESS WIRE)–E Ink (8069.TWO),…
GLENDALE, Calif. and NEW YORK–(BUSINESS WIRE)–PS Business Parks, Inc. (NYSE:PSB) (“PSB” or the “Company”) and…
25th April 2022: Ballymore Group founder and Group CEO Sean Mulryan has acquired a significant…
Castellum, Inc. Hires David T. Bell as Chief Financial Officer Castellum, Inc. (OTC: ONOV) announces…
Expanding Leadership Team to Accelerate Development of Innovative Therapeutic Delivery Platforms SAN DIEGO, April 25,…
– Q&A Session at Conference on Wednesday, April 27th at 1:30PM Eastern – AUSTIN, Texas,…
– Strategic areas of focus on development of BDTX-1535 and BDTX-4933 as well as MAP…
SAN DIEGO and PALO ALTO, Calif., April 25, 2022 (GLOBE NEWSWIRE) — Sorrento Therapeutics, Inc….
LAVAL, Québec, April 25, 2022 (GLOBE NEWSWIRE) — Acasti Pharma Inc. (“Acasti” or the “Company”)…
MIAMI, April 25, 2022 (GLOBE NEWSWIRE) — Veru Inc. (NASDAQ: VERU), a biopharmaceutical company, today…
BOSTON, April 25, 2022 (GLOBE NEWSWIRE) — Radius Health, Inc. (“Radius” or the “Company”) (Nasdaq:…
Quoin Will Initiate Clinical Testing in 1H 2022 ASHBURN, Va., April 25, 2022 (GLOBE NEWSWIRE)…
Preclinical data published in Molecular Therapy Nucleic Acids demonstrate that WVE-004 potently reduces C9orf72 transcriptional…
Chief Science Officer and CB Therapeutics co-founder, Dr. Jacob Vogan, working alongside Laboratory Manager, Diana…
The Company to Host a Conference Call and Webcast on May 11, 2022, at 8:30…
– Company advancing development of its Autoimmunity Modifying AIM Biologicals as a potential therapeutic treatment…
– Met pre-specified efficacy endpoints in chronic pouchitis, a difficult-to-treat inflammatory bowel disease (IBD)– AMT-101…
PURCHASE, N.Y., April 25, 2022 (GLOBE NEWSWIRE) — Cognition Therapeutics, Inc. (Nasdaq: CGTX), a clinical…